Published in Transplantation on January 27, 2005
Critical evaluation of the amino acid triplet-epitope matching concept in cadaver kidney transplantation. Transplantation (2004) 2.13
Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells (2004) 3.98
Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood (2003) 2.57
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55
Allo-HLA reactivity of virus-specific memory T cells is common. Blood (2010) 2.28
Peptide antagonism as a mechanism for NK cell activation. Proc Natl Acad Sci U S A (2010) 1.72
Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl Med (2013) 1.68
Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS One (2008) 1.67
Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet (2010) 1.67
HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion. Blood (2013) 1.65
Composition of human skin microbiota affects attractiveness to malaria mosquitoes. PLoS One (2011) 1.47
Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility. Transplantation (2007) 1.44
Evaluation of the Eurotransplant Senior Program. The results of the first year. Am J Transplant (2002) 1.26
Origin of lymph node-derived lymphocytes in human hepatic allografts. Clin Transpl (1989) 1.24
A cell-based approach to the minimization of immunosuppression in renal transplantation. Transpl Int (2008) 1.24
Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin. Transplantation (2008) 1.17
The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens. Transplantation (2004) 1.15
Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation (2008) 1.13
Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. J Reprod Immunol (2009) 1.11
The Dutch national living donor kidney exchange program. Am J Transplant (2005) 1.09
A highly divergent microsatellite facilitating fast and accurate DRB haplotyping in humans and rhesus macaques. Proc Natl Acad Sci U S A (2007) 1.08
Human monoclonal HLA antibodies reveal interspecies crossreactive swine MHC class I epitopes relevant for xenotransplantation. Mol Immunol (2009) 1.08
Early versus late acute rejection episodes in renal transplantation. Transplantation (2003) 1.05
Allogeneic MHC class I molecules with numerous sequence differences do not elicit a CTL response. Hum Immunol (2005) 1.05
HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival. Transplantation (2003) 1.04
Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells. Transplantation (2003) 1.03
Differential immunogenicity of HLA mismatches in clinical transplantation. Transpl Immunol (2005) 1.03
HLA matching for kidney transplantation. Hum Immunol (2004) 1.00
HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. Am J Transplant (2004) 0.99
Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors. Transplantation (2010) 0.97
Expression of NK cell receptors on decidual T cells in human pregnancy. J Reprod Immunol (2009) 0.97
Comparison of decidual leukocytes following spontaneous vaginal delivery and elective cesarean section in uncomplicated human term pregnancy. J Reprod Immunol (2004) 0.96
Blood cell mRNAs and microRNAs: optimized protocols for extraction and preservation. Blood (2013) 0.96
Extending options for highly sensitized patients to receive a suitable kidney graft. Curr Opin Immunol (2005) 0.96
Identification, isolation, and culture of HLA-A2-specific B lymphocytes using MHC class I tetramers. J Immunol (2003) 0.95
Structural aspects of HLA class I epitopes reacting with human monoclonal antibodies in Ig-binding, C1q-binding and lymphocytotoxicity assays. Hum Immunol (2013) 0.95
Human leukocyte antigen epitope analysis to assess complement- and non-complement-binding donor-specific antibody repertoire in a pediatric heart transplant recipient. Hum Immunol (2011) 0.95
Exclusive characteristics of graft survival and risk factors in recipients with immunoglobulin A nephropathy: a retrospective analysis of registry data. Transplantation (2005) 0.95
Differential immunomodulatory effects of fetal versus maternal multipotent stromal cells. Hum Immunol (2008) 0.95
Functional characteristics of lymphocytes propagated from a human multivisceral allograft. Clin Transplant (1990) 0.94
HLA-targeted flow cytometric sorting of blood cells allows separation of pure and viable microchimeric cell populations. Blood (2011) 0.93
Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program. Transplantation (2009) 0.93
EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail. J Immunol (2013) 0.93
HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients. Blood (2005) 0.93
Hurdles, barriers, and successes of a national living donor kidney exchange program. Transplantation (2008) 0.92
Loss or downregulation of HLA class I expression at the allelic level in acute leukemia is infrequent but functionally relevant, and can be restored by interferon. Hum Immunol (2002) 0.92
A broad and strong humoral immune response to donor HLA after implantation of cryopreserved human heart valve allografts. Hum Immunol (2002) 0.91
Tissue specificity of cross-reactive allogeneic responses by EBV EBNA3A-specific memory T cells. Transplantation (2011) 0.91
HLA-B62 and HLA-DQ8 are associated with Complex Regional Pain Syndrome with fixed dystonia. Pain (2009) 0.91
The ratio of interferon-gamma and interleukin-10 producing donor-specific cells as an in vitro monitoring tool for renal transplant patients. Transplantation (2006) 0.90
Relation between HLA genes, human skin volatiles and attractiveness of humans to malaria mosquitoes. Infect Genet Evol (2013) 0.90
Kinetics of the pregnancy-induced humoral and cellular immune response against the paternal HLA class I antigens of the child. Hum Immunol (2002) 0.88
Alloreactivity against repeated HLA mismatches of sequential islet grafts transplanted in non-uremic type 1 diabetes patients. Transplantation (2005) 0.88
Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study. Pigment Cell Res (2004) 0.88
How did a patient who types for HLA-B*4403 develop antibodies that react with HLA-B*4402? Hum Immunol (2009) 0.88
A flexible national living donor kidney exchange program taking advantage of a central histocompatibility laboratory: the Dutch model. Clin Transpl (2008) 0.88
ALLOREACTIVE T LYMPHOCYTES CULTURED FROM LIVER TRANSPLANT BIOPSIES: ASSOCIATIONS OF HLA SPECIFICITY WITH CLINICOPATHOLOGICAL FINDINGS. Clin Transplant (1988) 0.87
Vaccine-induced allo-HLA-reactive memory T cells in a kidney transplantation candidate. Transplantation (2011) 0.86
Major histocompatibility complex (MHC)-mediated immune regulation of decidual leukocytes at the fetal-maternal interface. J Reprod Immunol (2010) 0.86
Changes in cytokine production and composition of peripheral blood leukocytes during pregnancy are not associated with a difference in the proliferative immune response to the fetus. Hum Immunol (2011) 0.86
Differential immunogenicity of paternal HLA Class I antigens in pregnant women. Hum Immunol (2003) 0.86
HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates. Transpl Int (2003) 0.86
A proposed algorithm predictive for cytotoxic T cell alloreactivity. J Immunol (2012) 0.86
The influence of inherited and noninherited parental antigens on outcome after transplantation. Transpl Int (2006) 0.86
HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes. Hum Immunol (2005) 0.85
It takes six to boogie: allocating cadaver kidneys in Eurotransplant. Transplantation (2004) 0.85
Eight years of outcomes of the Dutch Living Donor Kidney Exchange Program. Clin Transpl (2011) 0.85
Characterization of the T-cell-mediated immune response against the Aspergillus fumigatus proteins Crf1 and catalase 1 in healthy individuals. J Infect Dis (2013) 0.85
HLA dosage effect in narcolepsy with cataplexy. Immunogenetics (2014) 0.85
The risk of cancer is not increased in patients with multiple kidney transplantations. Transpl Immunol (2012) 0.85
Incidence of cancer in kidney-transplant recipients: a long-term cohort study in a single center. Cancer Epidemiol (2010) 0.84
Differential distribution of NK cells in decidua basalis compared with decidua parietalis after uncomplicated human term pregnancy. Hum Immunol (2003) 0.84
Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Hepatology (2008) 0.84
High-resolution analysis of HLA class I alterations in colorectal cancer. BMC Cancer (2006) 0.84
Integrating in silico and in vitro analysis of peptide binding affinity to HLA-Cw*0102: a bioinformatic approach to the prediction of new epitopes. PLoS One (2009) 0.83
Impact of peptides on the recognition of HLA class I molecules by human HLA antibodies. J Immunol (2005) 0.83
Human monoclonal antibody reactivity with human leukocyte antigen class I epitopes defined by pairs of mismatched eplets and self-eplets. Transplantation (2010) 0.83
HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies. Transfusion (2014) 0.83
Detection and clinical relevance of donor specific HLA antibodies: a matter of debate. Transpl Int (2012) 0.83
Rapid assessment of the antigenic integrity of tetrameric HLA complexes by human monoclonal HLA antibodies. J Immunol Methods (2006) 0.82
Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals. Eur J Immunol (2014) 0.82
Egg donation pregnancy as an immunological model for solid organ transplantation. Transpl Immunol (2011) 0.82
Detection of donor-specific HLA antibodies before and after removal of a rejected kidney transplant. Transpl Immunol (2009) 0.82
HLAMatchmaker algorithm is not a suitable tool to predict the alloreactive cytotoxic T-lymphocyte response in vitro. Transplantation (2004) 0.82
Combined immunodeficiency due to MALT1 mutations, treated by hematopoietic cell transplantation. J Clin Immunol (2015) 0.82
Proteasome inhibition profoundly affects activated human B cells. Transplantation (2013) 0.82
Genetic HLA associations in complex regional pain syndrome with and without dystonia. J Pain (2012) 0.81
The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response. Transfus Med Rev (2005) 0.81
Transfusion-associated graft vs. host disease after donor-specific leukocyte transfusion before kidney transplantation. Clin Transplant (2003) 0.81
Differential effect of pretransplant blood transfusions on immune effector and regulatory compartments in HLA-sensitized and nonsensitized recipients. Transplantation (2010) 0.81
A highly efficient living donor kidney exchange program for both blood type and crossmatch incompatible donor-recipient combinations. Transplantation (2006) 0.81
No in vitro evidence for a decreased alloreactivity toward noninherited maternal HLA antigens in healthy individuals. Hum Immunol (2006) 0.81
Structural aspects of human leukocyte antigen class I epitopes detected by human monoclonal antibodies. Hum Immunol (2011) 0.81
The immunologic profile of infants born after maternal immunoglobulin treatment and intrauterine platelet transfusions for fetal/neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol (2004) 0.80
Beneficial or harmful effect of antipaternal human leukocyte antibodies on pregnancy outcome? A systematic review and meta-analysis. Am J Reprod Immunol (2013) 0.80
Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients. J Transl Med (2014) 0.80
C4d staining in renal allograft biopsies with early acute rejection and subsequent clinical outcome. Clin J Am Soc Nephrol (2011) 0.80